🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
Pharmacokinetics, Bioavailability, Safety and Immunogenicity of Single Dose...
Status
Completed
Location
Ppd Development
Start Date
2007-12
Trial ID
NCT00569803
Treatments Being Tested
This randomized, double-blind, parallel group study compares the efficacy a...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01194414
This is a phase 1/2a double-blinded, placebo-controlled, dose-escalating st...
Status
Recruiting
Location
Liverpool Hospital
Start Date
2024-03-04
Trial ID
NCT06138743
Treatments Being Tested
The main purpose of this study is to evaluate safety, tolerability, pharmac...
Status
Completed
Location
Nuvisan GmbH
Start Date
2021-08-03
Trial ID
NCT05018403
Treatments Being Tested
This three-part study will evaluate the pharmacokinetics and bioavailabilit...
Status
Completed
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT01654211
Treatments Being Tested
The purpose of the China Extension study is to assess the safety and effica...
Status
Completed
Location
Beijing Cancer Hospital (0601)
Start Date
2020-07-14
Trial ID
NCT04889118
Treatments Being Tested
This study evaluates the effect of giving preoperative adjuvant drug as pre...
Status
Completed
Location
National Cancer Institute
Start Date
2015-07
Trial ID
NCT02678117
Treatments Being Tested
This clinical study is a randomized, double-blind, double-dummy, parallel g...
Status
Suspended
Location
Sun City Clinical Research
Start Date
2022-12-14
Trial ID
NCT05324358
Treatments Being Tested
This is a Phase I, single-center, randomized, single-blind, placebo-control...
Status
Completed
Location
Charité Research
Start Date
2024-11-21
Trial ID
NCT07285603